Abstract:Adolescence is a late developmental period marked by pronounced reorganization of brain networks in which epigenetic mechanisms play a fundamental role. This brain remodeling is associated with a peculiar behavior characterized by novelty seeking and risky activities such as alcohol and drug abuse, which is associated with increased susceptibility to stress. Hence, adolescence is a vulnerable postnatal period since short- and long-term deleterious effects of alcohol drinking and drug abuse are a serious worldwide public health concern. Among several other consequences, it has been proposed that exposure to stress, alcohol, or other drugs disrupts epigenetic mechanisms mediated by small non-coding microRNAs (miRNAs). During adolescence, this modifies the expression of a variety of genes involved in neurodevelopmental processes such as proliferation, differentiation, synaptogenesis, neural plasticity, and apoptosis. Hence, the effect of miRNAs dysregulation during adolescence might contribute to a long-term impact on brain function. This systematic review focuses on the miRNA expression patterns in the adolescent rodent brain with special interest in the impact of stress and drugs such as amphetamine, cocaine, nicotine, cannabis, and ketamine. The results point to a relevant and complex role of miRNAs in the regulation of the molecular processes involved in adolescent brain development as part of a dynamic epigenetic network sensitive to environmental events with distinctive changes across adolescence. Several miRNAs have been assessed evidencing changing expression profiles during the adolescent transition which are altered by exposure to stress and drug abuse. Since this is an emerging rapidly growing field, updating the present knowledge will contribute to improving our understanding of the epigenetic regulation mechanisms involved in the neurodevelopmental changes responsible for adolescent behavior. It can be expected that increased knowledge of the molecular mechanisms mediating the effect of environmental threats during the adolescent critical developmental period will improve understanding of psychiatric and addictive disorders emerging at this stage.

MicroRNA-dependent control of neuroplasticity in affective disorders

Blood Mir-144-3p: a Novel Diagnostic and Therapeutic Tool for Depression

Prospective Role of MicroRNAs in Depression

Synaptic plasticity and depression: the role of miRNAs dysregulation

miRNA regulation of social and anxiety-related behaviour

A New Player in Depression: MiRNAs as Modulators of Altered Synaptic Plasticity

MicroRNAs and Child Neuropsychiatric Disorders: A Brief Review

Diagnostic and mechanistic roles of MicroRNAs in neurodevelopmental & neurodegenerative disorders

MicroRNA-451a is a candidate biomarker and therapeutic target for major depressive disorder

MicroRNA mediators of early life stress vulnerability to depression and suicidal behavior

Impulsivity and comorbid traits: a multi-step approach for finding putative responsible microRNAs in the amygdala

Clinical and preclinical evaluation of miR-144-5p as a key target for major depressive disorder

Evidence for Selective Micrornas and Their Effectors As Common Long-Term Targets for the Actions of Mood Stabilizers

Microbial regulation of microRNA expression in the amygdala and prefrontal cortex

MicroRNA-Messenger RNA Regulatory Network Mediates Disrupted TH17 Cell Differentiation in Depression

MiR-184-3p in the paraventricular nucleus participates in the neurobiology of depression via regulation of the hypothalamus-pituitary-adrenal axis

MicroRNAs in addiction: adaptation's middlemen?

Exploratory Analysis of MicroRNA Alterations in a Neurodevelopmental Mouse Model for Autism Spectrum Disorder and Schizophrenia

MicroRNA Regulation of the Environmental Impact on Adolescent Neurobehavioral Development: A Systematic Review

Bridging Molecular Discoveries and Therapeutic Potential

MicroRNA132 associated multimodal neuroimaging patterns in unmedicated major depressive disorder.